First line PD-1 inhibitor, Serplulimab Plus Chemoradiotheraphy for Extensive Stage Thymic Carcinoma: A Case Report

Muhammad HAFIZ; Aziza GHANIE ICKSAN; Sita ANDARINI; Annisa Dian HARLIVASARI

doi:10.5505/tjo.2026.4783

Current Issue

Forthcoming Issue

Archive

Supplements

Türkçe

The Official Journal of Turkish Society for Radiation Oncology

TURKISH JOURNAL OF ONCOLOGY 2026 , Vol 41 , Num 2

Abstract Full Text PDF Similar Articles Mail to Author

First line PD-1 inhibitor, Serplulimab Plus Chemoradiotheraphy for Extensive Stage Thymic Carcinoma: A Case Report

Muhammad HAFIZ¹, Aziza GHANIE ICKSAN², Sita ANDARINI³, Annisa Dian HARLIVASARI¹

¹Department of Pulmonology and Respiratory Medicine, Budhi Asih Hospital, Jakarta-Indonesia
²Department of Radiology, Universitas PRIMA, Medan-Indonesia
³Division of Thoracic Oncology, Department of Pulmonology and Respiratory Medicine, Universitas Indonesia Faculty of Medicine, Persahabatan Hospital, Jakarta-Indonesia DOI : 10.5505/tjo.2026.4783 Keywords :

Home

Informations For Authors

Retractions

Contact